Provident Wealth Management’s T. Rowe Price US Equity Research ETF TSPA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$64.1M Sell
1,349,256
-21,968
-2% -$1.01M 16.51% 1
2026
Q1
$56.1M Sell
1,371,224
-10,922
-0.8% -$467K 16.96% 1
2025
Q4
$59.1M Buy
1,382,146
+11,254
+0.8% +$479K 17.51% 1
2025
Q3
$57.5M Sell
1,370,892
-2,531
-0.2% -$102K 17.38% 1
2025
Q2
$53.4M Sell
1,373,423
-10,295
-0.7% -$370K 17.47% 1
2025
Q1
$48.7M Buy
1,383,718
+15,209
+1% +$563K 16.76% 1
2024
Q4
$50.6M Buy
1,368,509
+63,681
+5% +$2.36M 16.88% 1
2024
Q3
$47.1M Buy
1,304,828
+35,371
+3% +$1.23M 16.08% 1
2024
Q2
$43.7M Buy
1,269,457
+672,333
+113% +$22.1M 15.97% 1
2024
Q1
$19.6M Buy
+597,124
New +$18.5M 7.34% 5

Other funds holding TSPA

Provident Wealth Management's TSPA Position: Q2 2026 in Review

Provident Wealth Management reduced its T. Rowe Price US Equity Research ETF (TSPA) stake by 1.6% in Q2 2026, selling an estimated $1.01M and leaving 1,349,256 shares worth $64.1M. The position accounts for 16.51% of the portfolio, ranked #1.

Provident Wealth Management first reported a position in TSPA in Q1 2024 and has held it in 10 quarters since. 137 funds tracked by Wall St. Rank hold TSPA as of Q2 2026.

  • Provident Wealth Management held 1,349,256 shares of T. Rowe Price US Equity Research ETF worth $64.1M as of Q2 2026.
  • Provident Wealth Management sold 21,968 T. Rowe Price US Equity Research ETF shares in Q2 2026, an estimated $1.01M.
  • T. Rowe Price US Equity Research ETF made up 16.51% of Provident Wealth Management's portfolio in Q2 2026, its #1 holding.
  • Provident Wealth Management first reported a position in T. Rowe Price US Equity Research ETF in Q1 2024 and has held it in 10 quarters since.
  • 137 funds tracked by Wall St. Rank held T. Rowe Price US Equity Research ETF as of Q2 2026.

Based on Provident Wealth Management's 13F filing for Q2 2026, filed 4 Aug 2026.